Skip to content

Warby Parker WRBY Eye care — Net revenue

Other product segments

Eyewear
$201.44M+7.2%
Contacts Products
$97.15M+23.4%
Contacts
$24.18M

Similar metrics at other companies

Bausch + Lomb logo
BLCOVision Care — Total revenues
$711M+8.4%
Glaukos logo
GKOSCorneal Health — Revenue
$21.31M+15.0%
iRhythm Holdings, Inc.
 logo
IRTCCustomer A — Revenue, net
$30.15M+13.1%
Glaukos logo
GKOSGlaucoma — Revenue
$129.26M+46.7%
Johnson & Johnson logo
JNJCONTACTLENSESOTHER — Sales to customers (Note 9)
$969M+5.4%
Resideo Technologies, Inc. logo
REZIEnergy — Net revenue
$156M+12.2%

Other financials

Income statement

See full
Revenue$242.4M+8.3%
Gross profit$131.0M+4.0%
Operating income$1.7M-32.5%
Net income$3.2M-8.5%
EPS (diluted)$0.030.0%

Balance sheet

See full
Cash & equivalents$288.2M+8.7%
Total debt$237.6M+6.2%
Total equity$375.8M+6.1%
Total assets$736.4M+7.9%

Cash flow

See full
Operating cash flow$24.5M-16.5%
CapEx$16.1M-0.1%
Free cash flow$8.4M-36.6%

Valuation

See full
Market cap$3.19B+17.1%
Enterprise value$3.14B+17.0%
P/E295.8×
P/S3.6×+0.2×

Profitability

See full
Gross margin53.4%-1.8pp
Operating margin-0.7%-0.3pp
Net margin0.1%0.0pp
FCF margin4.5%-0.8pp

Returns & leverage

See full
Return on equity0.2%+0.1pp
Debt / equity0.6×0.0×
Current ratio2.3×-0.4×

Where this comes from

Reported directly by Warby Parker in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Warby Parker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Warby Parker's eye care — net revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Warby Parker's eye care — net revenue?
Warby Parker (WRBY) reported eye care — net revenue of $16.82M in Q1 2026.
What does eye care — net revenue mean?
This metric represents the total gross revenue generated from professional eye care services, including comprehensive eye exams and vision testing. It reflects the company's ability to monetize clinical services as a distinct revenue stream alongside its core retail eyewear offerings. Growth in this segment indicates successful integration of health services into the consumer experience and expansion of the total addressable market beyond physical product sales.